Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 597
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01446952 | Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects | ||
| NCT00215943 | Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) | ||
| NCT01434550 | Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic Cancer | ||
| NCT03927274 | Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma | ||
| NCT00816985 | Liposuction for Arm Lymphedema Following Breast Cancer Surgery | ||
| NCT00815750 | Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients | ||
| NCT05064085 | Capecitabine In Combination With Cemiplimab In Patient With Metastatic Breast Cancer | ||
| NCT05041335 | Wet Heparinized Suction for Abdominal Cancer | ||
| NCT00762255 | A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent Glioblastoma | ||
| NCT05115474 | Study of Screening Brain MRIs in Stage IV Breast Cancer | ||
| NCT00006085 | CP-609,754 in Treating Patients With Advanced Solid Tumors | ||
| NCT00006376 | R115777 in Treating Patients With Advanced Bladder Cancer | ||
| NCT01269645 | Facts and Attitudes About Clinical Trials | ||
| NCT00351039 | Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer | ||
| NCT02935309 | Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma | ||
| NCT01042535 | Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer | ||
| NCT01822691 | Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS) | ||
| NCT05438940 | Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients | ||
| NCT01662609 | Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic Cancer | ||
| NCT01951976 | Yoga for Aromatase Inhibitor-associated Joint Pain | ||
| NCT05649969 | STRONG Program for Cancer Patients | ||
| NCT05628883 | Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma | ||
| NCT00365222 | Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma | ||
| NCT01496807 | Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma | ||
| NCT05054218 | COVID-19 Immunogenicity of a Third Dose of mRNA-1273 Vaccine Among Cancer Patients | ||
| NCT03575325 | Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia | ||
| NCT01852591 | Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant | ||
| NCT05579847 | Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy | ||
| NCT02948946 | Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors | ||
| NCT00617591 | Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM) | ||
| NCT02363491 | A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome | ||
| NCT03377023 | Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung Cancer | ||
| NCT05379933 | Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of Life | ||
| NCT03384914 | Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer | ||
| NCT04975152 | Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma | ||
| NCT03406715 | Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC) | ||
| NCT03514017 | Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia | ||
| NCT01908777 | A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma | ||
| NCT03381183 | IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma | ||
| NCT04760847 | Intermittent Fasting for Pancreatitis | ||
| NCT02139358 | Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer | ||
| NCT03758781 | IRX-2 Regimen Combined With Nivolumab in Recurrent/Metastatic Solid Tumors | ||
| NCT03611738 | Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC | ||
| NCT00005800 | Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer | ||
| NCT01432600 | Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide | ||
| NCT04914000 | Motivating a Spectrum of Cancer Patients to Quit Smoking | ||
| NCT06002126 | Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries | ||
| NCT00617617 | The Specific Role of Isoflavones in Reducing Prostate Cancer Risk | ||
| NCT02115542 | Single Agent Regorafenib in Refractory Advanced Biliary Cancers | ||
| NCT06328127 | Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors |
